Search Page

1

Cite

Share

The Future of Brain Imaging in Parkinson's Disease.

Helmich RC, Vaillancourt DE, Brooks DJ. Helmich RC, et al. Among authors: vaillancourt de. J Parkinsons Dis. 2018;8(s1):S47-S51. doi: 10.3233/JPD-181482. J Parkinsons Dis. 2018. PMID: 30584163 Free PMC article. Review.

Cite

Share

2

Cite

Share

Aducanumab reduces Aβ plaques in Alzheimer's disease.

Vaillancourt DE. Vaillancourt DE. Mov Disord. 2016 Nov;31(11):1631. doi: 10.1002/mds.26833. Epub 2016 Oct 14. Mov Disord. 2016. PMID: 27739124 Review. No abstract available.

Cite

Share

3

Cite

Share

A two-year randomized controlled trial of progressive resistance exercise for Parkinson's disease.

Corcos DM, Robichaud JA, David FJ, Leurgans SE, Vaillancourt DE, Poon C, Rafferty MR, Kohrt WM, Comella CL. Corcos DM, et al. Among authors: vaillancourt de. Mov Disord. 2013 Aug;28(9):1230-40. doi: 10.1002/mds.25380. Epub 2013 Mar 27. Mov Disord. 2013. PMID: 23536417 Free PMC article. Clinical Trial.

Cite

Share

4

Cite

Share

Repetitive Transcranial Magnetic Stimulation (rTMS) Therapy in Parkinson Disease: A Meta-Analysis.

Wagle Shukla A, Shuster JJ, Chung JW, Vaillancourt DE, Patten C, Ostrem J, Okun MS. Wagle Shukla A, et al. Among authors: vaillancourt de. PM R. 2016 Apr;8(4):356-366. doi: 10.1016/j.pmrj.2015.08.009. Epub 2015 Aug 24. PM R. 2016. PMID: 26314233 Free PMC article. Review.

Cite

Share

5

Cite

Share

Neurite orientation dispersion and density imaging (NODDI) and free-water imaging in Parkinsonism.

Mitchell T, Archer DB, Chu WT, Coombes SA, Lai S, Wilkes BJ, McFarland NR, Okun MS, Black ML, Herschel E, Simuni T, Comella C, Xie T, Li H, Parrish TB, Kurani AS, Corcos DM, Vaillancourt DE. Mitchell T, et al. Among authors: vaillancourt de. Hum Brain Mapp. 2019 Dec 1;40(17):5094-5107. doi: 10.1002/hbm.24760. Epub 2019 Aug 12. Hum Brain Mapp. 2019. PMID: 31403737 Free PMC article.

Cite

Share

6

Cite

Share

Exercise improves cognition in Parkinson's disease: The PRET-PD randomized, clinical trial.

David FJ, Robichaud JA, Leurgans SE, Poon C, Kohrt WM, Goldman JG, Comella CL, Vaillancourt DE, Corcos DM. David FJ, et al. Among authors: vaillancourt de. Mov Disord. 2015 Oct;30(12):1657-63. doi: 10.1002/mds.26291. Epub 2015 Jul 6. Mov Disord. 2015. PMID: 26148003 Free PMC article. Clinical Trial.

Cite

Share

7

Cite

Share

Effects of 2 Years of Exercise on Gait Impairment in People With Parkinson Disease: The PRET-PD Randomized Trial.

Rafferty MR, Prodoehl J, Robichaud JA, David FJ, Poon C, Goelz LC, Vaillancourt DE, Kohrt WM, Comella CL, Corcos DM. Rafferty MR, et al. Among authors: vaillancourt de. J Neurol Phys Ther. 2017 Jan;41(1):21-30. doi: 10.1097/NPT.0000000000000163. J Neurol Phys Ther. 2017. PMID: 27977518 Free PMC article. Clinical Trial.

Cite

Share

8

Cite

Share

Magnetic Resonance Imaging and Neurofilament Light in the Differentiation of Parkinsonism.

Archer DB, Mitchell T, Burciu RG, Yang J, Nigro S, Quattrone A, Quattrone A, Jeromin A, McFarland NR, Okun MS, Vaillancourt DE. Archer DB, et al. Among authors: vaillancourt de. Mov Disord. 2020 Aug;35(8):1388-1395. doi: 10.1002/mds.28060. Epub 2020 May 1. Mov Disord. 2020. PMID: 32357259

Cite

Share

9

Cite

Share

Imaging Markers of Progression in Parkinson's Disease.

Strafella AP, Bohnen NI, Pavese N, Vaillancourt DE, van Eimeren T, Politis M, Tessitore A, Ghadery C, Lewis S; IPMDS‐Neuroimaging Study Group. Strafella AP, et al. Among authors: vaillancourt de. Mov Disord Clin Pract. 2018 Oct 9;5(6):586-596. doi: 10.1002/mdc3.12673. eCollection 2018 Nov-Dec. Mov Disord Clin Pract. 2018. PMID: 30637278 Free PMC article. Review.

Cite

Share

10

Cite

Share

Illuminating basal ganglia and beyond in Parkinson's disease.

Vaillancourt DE, Lehericy S. Vaillancourt DE, et al. Mov Disord. 2018 Sep;33(9):1373-1375. doi: 10.1002/mds.27483. Mov Disord. 2018. PMID: 30311976 Free article. No abstract available.

Cite

Share